Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 186 (TMEM186) is a mitochondrial transmembrane protein encoded by the TMEM186 gene, located on human chromosome 16[2][7][8]. TMEM186 is a component of the MCIA complex (mitochondrial complex I assembly), where it is required for the efficient assembly of mitochondrial complex I, crucial for cellular energy production through respiratory electron transport[2][3][4][9]. Variants of TMEM186 have been associated with rare congenital disorders of glycosylation and some aspects of mitochondrial disease, but its precise biological mechanisms remain to be fully characterized[2][6][9]. As of current knowledge, TMEM186 is not a druggable therapeutic target, has no validated biomarker role, and no direct pharmacological interactions are established. Its primary annotation in disease comes from genetic and pathway studies rather than clinical application[2][4][7][9].
None identified
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 186 (TMEM186).